Hereditary haemochromatosis

QJM: An International Journal of Medicine

Volumn 97, Issue 6, 2004, Pages 315-324

  Limdi, J K ^b   Crampton, J R ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HEMOGLOBIN; HEPCIDIN; HFE PROTEIN; IRON; TRANSFERRIN;

ARTHROPATHY; AUTOSOMAL RECESSIVE INHERITANCE; CAUCASIAN; CHROMOSOME 7Q; CLINICAL FEATURE; DIABETES MELLITUS; FATIGUE; GENE LOCUS; GENE MAPPING; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HEPATOMEGALY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTESTINE ABSORPTION; IRON ABSORPTION; LETHARGY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALAISE; MASS SCREENING; MISSENSE MUTATION; PHENOTYPE; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION;

EID: 3042542834     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch065     Document Type: Review

References (77)

1. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000; 4:183-98.
2. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and haemochromatosis: at the crossroads. Gastroenterology 1999; 116:193-207.
3. Ryan E, O'Keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998; 24:428-32.
4. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population-implications for haemochromatosis. Tissue Antigens 1998; 52:484-8.
5. Ryan F, Vaughan J. HFE mutation analysis in a normal Irish population. Br J Biomed Sci 2000; 57:315-16.
6. Byrnes V, Ryan E, Barrett S, Kenny P, Mayne P, Crowe J. Genetic haemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 2001; 5:127-30.
7. Trousseau A. Glycosurie, diabete sucre. Clinique Medicale de l'Hotel-Dieu de Paris, 2nd edn, Vol 2. Paris, Bailliere, 1865:65.
8. von Recklinghausen FD. Uber Haemochromatose. Heidelberg, Taggelblatt der (62) Versammlung deutscher Naturforscher and Aerzte in Heidelberg, 1889:324-5.
9. Sheldon JH. Haemochromatosis. London, Oxford University Press, 1935.
10. Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 1976; 17:332-4.
11. Simon M, Le Mignon L, Fauchet R, Yaouang J, David V, Edan G, Bourel M. A study of 609 HLA haplotypes marking for the haemochromatosis gene: (1) mapping of the gene near the HLA - A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of haemochromatosis - HLA association. Am J Hum Genet 1987; 41:89-105.
12. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
13. Bodmer JG, Parham P, Albert ED, Marsh SG. Putting a hold on 'HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System. Nature Genet 1997; 15:234-5.
14. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of haemochromatosis. Blood 1999; 93:2502-5.
15. Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test. 2000; 4:151-61.
16. Papanikolaou G, Politou M, Terpos E, Fourlemadis S, Sakellaropoulos N, Loukopoulos D. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 2000; 26:163-8.
17. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked haemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998; 114:1003-8.
18. de Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 2001; 9:961-4.
19. Bauduer F, Scribans C, Renoux M, Borot N. Genetic hemochromatosis is a rare disease entity among French Basques: a center-based study from the general hospital of Basque County. Ann Hematol 2001; 80:472-3.
20. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol 2001; 154:193-206.
21. Roetto A, Totaro A, Cazzola M, Cicilano M, Bosio S, D'Ascola G, Carella M, Zelante L, Kelly AL, Cox TM, Gasparini P, Camaschella C. Juvenile haemochromatosis locus maps to chromosome 1q. Am J Hum Genet 1999; 64:1388-93.
22. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003; 33:21-2.
23. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2003; 36:77-82.
24. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000; 25:14-15.
25. Pietrangelo A, Montosi G, Totaro A, Garuti C, Conte D, Cassanelli S, Fraquelli M, Sardini C, Vasta F, Gasparini P. Hereditary haemochromatosis in adults without pathogenic mutations in the haemochromatosis gene. N Engl J Med 1999; 341:725-2.
26. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A. Autosomal-dominant haemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108:619-23.
27. Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary haemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997; 94:2534.
28. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, Britton RS, Bacon BR, Sly WS. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999; 96:1579-84.
29. Kuhn LC. Iron overload: molecular clues to its cause. Trends Biochem Sci 1999; 24:164-6.
30. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999; 353:2120-3.
31. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403:776-81.
32. Pietrangelo A. Physiology of iron transport and the HFE gene. Am J Physiol 2002; 282:6403-14.
33. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276:7806-10.
34. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480:147-50.
35. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276:7811-19.
36. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anaemia of inflammation. Blood 2003; 102:783-8.
37. Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, Sly WS, Fleming RE. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 2002; 29:361-6.
38. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003; 361:669-73.
39. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000; 33:485-504.
40. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long term survival in patients with hereditary haemochromatosis. Gastroenterology 1996; 110:1107.
41. Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, Jouanolle H, Campion JP, Launois B, Halliday JW, et al. Primary liver cancer in genetic haemochromatosis: clinical pathological and pathogenic study of 54 cases. Gastroenterology 1993; 104:228-34.
42. Powell LW, Yapp TR. Hemochromatosis. Clin Liver Dis 2000; 4:211-28, viii.
43. Tweed MJ, Roland JM. Haemochromatosis as an endocrine cause of subfertility. Br Med J 1998; 316:915-16.
44. Faraawi R, Harth M, Kertesz A, Bell D. Arthritis in haemochromatosis. J Rheumatol 1993; 20:448.
45. Bacon BR, Sadiq S. Hereditary haemochromatosis: diagnosis in the 1990's. Am J Gastroenterol 1997; 92:784-9.
46. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of haemochromatosis: a changing scene. Am J Med 1991; 90:445.
47. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102:2108-13.
48. Bacon BR, Faravesh MJ, Janney CG, Neuschwander-Tetri BA. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107:1103-9.
49. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic haemochromatosis. Dig Dis Sci 1982; 27:909-16.
50. McCullen MA, Crawford DH, Hickman PE. Screening for haemochromatosis. Clin Chim Acta 2002; 315:169-86.
51. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of haemochromatosis in young subjects: Predictive accuracy of biochemical screening tests. Gastroenterology 1984; 87:628-33.
52. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary haemochromatosis. Gastroenterology 2002; 122:281-9.
53. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-24.
54. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-18.
55. Poullis A, Moodie SJ, Maxwell JD. Clinical haemochromatosis in HFE mutation carriers. Lancet 2002; 360:411-12; author reply 413-14.
56. Allen KJ, Warner B, Delatycki MB. Clinical haemochromatosis in HFE mutation carriers. Lancet 2002; 360:412-13; author reply 413-14.
57. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, David V, et al. Non-invasive prediction of fibrosis in C282Y homozygous haemochromatosis. Gastroenterology 1998; 115:929-36.
58. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with haemochromatosis and other liver diseases. Ann Int Med 1999; 130:953-62.
59. Morrison ED, Brandhagen DJ, Phatak PD. Serum ferritin level predicts advanced hepatic fibrosis among U. S. patients with phenotypic haemochromatosis. Ann Int Med 2003; 138:627-33.
60. Tavill AS. Diagnosis and management of haemochromatosis. AASLD Practice Guidelines. Hepatology 2001; 33:1321-8.
61. Brittenham GM, Weiss G, Brissot P, Laine F, Guillygomarc'h A, Guyader D, Moirand R, Deugnier Y. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism. Hematology (Am Soc Hematol Educ Program) 2000;:39-50.
62. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Path Bact 1962; 84:53-64.
63. George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999; 31:47-52.
64. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M, Bourel M, Carsin M, Brissot P. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic haemochromatosis. Gastroenterology 1999; 97:737-43.
65. Guyader D, Gandon Y, Robert JY, Heautot JF, Jouanolle H, Jacquelinet C, Messner M, Deugnier Y, Brissot P. Magnetic resonance imaging and assessment of liver iron content in genetic haemochromatosis. J Hepatol 1992; 15:304-8.
66. Stark DD. Hepatic iron overload: paramagnetic pathology. Radiology 1991; 179:333-5.
67. Pietrangelo A. Haemochromatosis. Gut 2003; 52(Suppl. 2): ii 23-30.
68. Cunningham E. Is there a role for diet in the treatment of haemochromatosis? J Am Diet Assoc 2003; 103:593.
69. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998; 129:932-9.
70. Farrell FJ, Nguyen KM, Woodley S, Imperial JC, Garcia-Kennedy R, Man K, Esquivel CO, et al. Outcome of liver transplantation in patients with haemochromatosis. Hepatology 1994; 20:404-10.
71. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, Sorrell MF, Bacon BR, Weber FL Jr, Tavill AS. Primary liver cancer and survival in hereditary haemochromatosis patients undergoing orthotopic liver transplantation. Liver Transplant Surg 1995; 1:237-241.
72. Tung BY, Farrell FJ, McCashland TM, Gish RG, Bacon BR, Keeffe EB, Kowdley KV. Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999; 5:369-74.
73. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52(Suppl. 3):iii 1-8.
74. El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary haemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000; 132:261-9.
75. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998; 280:172-8.
76. Delatycki M, Allen K, Williamson R. Insurance agreement to facilitate genetic testing. Lancet 2002; 359:1433.
77. Gertig DM, Hopper JL, Allen KJ. Population genetic screening for hereditary haemochromatosis. Med J Aust 2003; 179:517-18.